Literature DB >> 24375016

Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients.

Paolo Solla1, Antonino Cannas, Cesare Salvatore Mulas, Silvia Perra, Andrea Corona, Pier Paolo Bassareo, Francesco Marrosu.   

Abstract

Although fatigue is a common non-motor symptom in patients affected by Parkinson's disease (PD), its association with motor and other non-motor symptoms is still largely unclear. We assessed fatigue in PD patients studying the possible association with motor and non-motor symptoms. Eighty-one PD patients were included in the study. The PD Fatigue Scale (PFS) and the Fatigue Severity Scale (FSS) scale were used to measure fatigue. Non-motor symptoms were assessed with the Non-Motor Symptoms Scale (NMSS). Motor impairment was assessed using the modified Hoehn and Yahr (HY) staging and the Unified PD Rating Scale (UPDRS) part-III and IV. Bivariate tests comparing all independent variables between patients with our without fatigue were used. Significant predictors of presence and severity of fatigue were determined with different models of logistic regression analyses. Fatigue severity was significantly higher in female patients. Bivariate test showed significant higher NMSS score in fatigued patients according to PFS (p < 0.00001) and FFS (p < 0.001), while HY was higher only in fatigued patients according to FSS (p < 0.022). Significant correlations between severity of fatigue and HY stage (p < 0.002) and UPDRS-III score (p < 0.001) were found, while, among specific non-motor symptoms, anhedonia presented with the most significant correlation (p < 0.003). Binary logistic regression confirmed NMSS as the main variable predicting presence of fatigue, while HY was significant as predicting variable only in the FSS model. Strongest non-motor symptoms predictors of severity were those included in Domain 3 (mood/anxiety) and Domain 2 (sleep disorders) of the NMSS. A significant increase in severity of fatigue related to the burden of non-motor symptoms (mainly affective and sleep disorders) was observed. Our findings indicate a moderate discrepancy in the ratings of the two fatigue scales, with PFS principally directed towards the burden of non-motor symptoms. Finally, the accurate individuation of the factors underlying fatigue, assessed with the systematic administration of holistic evaluation scales such as the NMSS, might improve current strategies used in the treatment of this disabling condition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24375016     DOI: 10.1007/s00415-013-7207-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

Review 1.  Fatigue in Parkinson's disease: a short update.

Authors:  A G Beiske; E Svensson
Journal:  Acta Neurol Scand Suppl       Date:  2010

2.  The Parkinson fatigue scale.

Authors:  R G Brown; A Dittner; L Findley; S C Wessely
Journal:  Parkinsonism Relat Disord       Date:  2005-01       Impact factor: 4.891

3.  Fatigue in levodopa-naive subjects with Parkinson disease.

Authors:  G Schifitto; J H Friedman; D Oakes; L Shulman; C L Comella; K Marek; S Fahn
Journal:  Neurology       Date:  2008-08-12       Impact factor: 9.910

4.  Fatigue in patients with Parkinson's disease.

Authors:  K Karlsen; J P Larsen; E Tandberg; K Jørgensen
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

Review 5.  The Parkinson's complex: parkinsonism is just the tip of the iceberg.

Authors:  J William Langston
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Symptomatic fatigue in multiple sclerosis.

Authors:  J E Freal; G H Kraft; J K Coryell
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

8.  Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.

Authors:  Jau-Shin Lou; Greg Kearns; Theodore Benice; Barry Oken; Gary Sexton; John Nutt
Journal:  Mov Disord       Date:  2003-10       Impact factor: 10.338

9.  The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals.

Authors:  D Irvine; L Vincent; J E Graydon; N Bubela; L Thompson
Journal:  Cancer Nurs       Date:  1994-10       Impact factor: 2.592

10.  The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation project.

Authors:  Vinod Metta; Kartik Logishetty; P Martinez-Martin; Heather M Gage; P E S Schartau; T K Kaluarachchi; Anne Martin; Per Odin; P Barone; Fabrizio Stocchi; A Antonini; K Ray Chaudhuri
Journal:  Parkinsons Dis       Date:  2011-12-05
View more
  12 in total

1.  The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson's disease patients.

Authors:  Ioannis E Dagklis; Efthymia Tsantaki; Dimitrios Kazis; Varvara Theodoridou; Sotirios Papagiannopoulos; Dimitrios Ntantos; Sevasti Bostantjopoulou
Journal:  Neurol Sci       Date:  2019-01-08       Impact factor: 3.307

2.  Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease.

Authors:  Sneha Mantri; Lana M Chahine; Karina Nabieva; Robert Feldman; Andrew Althouse; Benjamin Torsney; Steven M Albert; Catherine Kopil; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2021-10-28

Review 3.  Anhedonia in Neurodegenerative Diseases.

Authors:  Vicky Turner; Masud Husain
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Fatigue is associated with high prevalence and severity of physical and emotional symptoms in patients on chronic hemodialysis.

Authors:  Maurizio Bossola; Enrico Di Stasio; Emanuele Marzetti; Katja De Lorenzis; Gilda Pepe; Carlo Vulpio
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

5.  Turkish version of Parkinson Fatigue Scale: Validity and reliability study of binary scoring method.

Authors:  Erhan Arif Öztürk; Bilge Gönenli Koçer; Ebru Umay; Aytül Çakcı
Journal:  Turk J Phys Med Rehabil       Date:  2018-02-26

6.  Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment.

Authors:  Rao Fu; Xiao-Guang Luo; Yan Ren; Zhi-Yi He; Hong Lv
Journal:  Transl Neurodegener       Date:  2016-05-10       Impact factor: 8.014

7.  Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients.

Authors:  Rao Fu; Shi-Shuang Cui; Juan-Juan Du; Pei Huang; Ya-Chao He; Chao Gao; Xiao-Guang Luo; Sheng-Di Chen
Journal:  Brain Behav       Date:  2017-05-02       Impact factor: 2.708

8.  Fatigue is associated with the onset of hallucinations in patients with Parkinson's disease: A 3-year prospective study.

Authors:  Masanori Ikeda; Hiroshi Kataoka; Satoshi Ueno
Journal:  eNeurologicalSci       Date:  2016-04-16

9.  Nonmotor Features in Parkinson's Disease: What Are the Most Important Associated Factors?

Authors:  Liis Kadastik-Eerme; Mari Muldmaa; Stella Lilles; Marika Rosenthal; Nele Taba; Pille Taba
Journal:  Parkinsons Dis       Date:  2016-04-19

Review 10.  Disentangling fatigue from anhedonia: a scoping review.

Authors:  Ruel R Billones; Saloni Kumar; Leorey N Saligan
Journal:  Transl Psychiatry       Date:  2020-08-07       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.